Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Quigley, David A., Dang, Ha X., Zhao, Shuang G., Lloyd, Paul, Aggarwal, Rahul, Alumkal, Joshi J., Foye, Adam, Kothari, Vishal, Perry, Marc D., Bailey, Adina M., Playdle, Denise, Barnard, Travis J., Zhang, Li, Zhang, Jin, Youngren, Jack F., Cieslik, Marcin P., Parolia, Abhijit, Beer, Tomasz M., Thomas, George, Chi, Kim N., Gleave, Martin, Lack, Nathan A., Zoubeidi, Amina, Reiter, Robert E., Rettig, Matthew B., Witte, Owen, Ryan, Charles J., Fong, Lawrence, Kim, Won, Friedlander, Terence, Chou, Jonathan, Li, Haolong, Das, Rajdeep, Li, Hui, Moussavi-Baygi, Ruhollah, Goodarzi, Hani, Gilbert, Luke A., Lara, Primo N., Evans, Christopher P., Goldstein, Theodore C., Stuart, Joshua M., Tomlins, Scott A., Spratt, Daniel E., Cheetham, R. Keira, Cheng, Donavan T., Farh, Kyle, Gehring, Julian S., Hakenberg, Jörg, Liao, Arnold, Febbo, Philip G., Shon, John, Sickler, Brad, Batzoglou, Serafim, Knudsen, Karen E., He, Housheng H., Huang, Jiaoti, Wyatt, Alexander W., Dehm, Scott M., Ashworth, Alan, Chinnaiyan, Arul M., Maher, Christopher A., Small, Eric J., Feng, Felix Y.·2018·Cell
DOI 10.1016/j.cell.2018.06.039

Cited by (738)

Items 701–738 of 738

  1. TP53 P72R Polymorphism Is Associated With P53 Protein Expression in Fatal Prostate Cancer: A Novel Case Report and Review of the Literature
    Pooria Asili, Jordan Selep, Coen Johannes Gerardus Lap, Maneesh Jain, Victor E. Nava · 2025 · Cureus
  2. Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas
    Aglaya G. Iyevleva, Светлана Николаевна Алексахина, Анна Петровна Соколенко, Екатерина Андреевна Отраднова, Алиса Сергеевна Никитина, Кира Антоновна Кашко, Maria V. Syomina, Анна Дмитриевна Шестакова, Ekatherina Sh. Kuligina, Natalia S. Morozova et al. · 2025 · International Journal of Molecular Sciences
  3. Additional file 3 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
    Wang, Zefeng, Chao, Zheng, Wang, Qi, Fan Zou, Tianbao Song, Lizhe Xu, Ning, Jinzhuo, Cheng, Fan · 2024 · Figshare
  4. Additional file 5 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
    Wang, Zefeng, Zheng Chao, Wang, Qi, Fan Zou, Tianbao Song, Lizhe Xu, Ning, Jinzhuo, Cheng, Fan · 2024 · Figshare
  5. Additional file 4 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
    Wang, Zefeng, Zheng Chao, Wang, Qi, Fan Zou, Tianbao Song, Lizhe Xu, Ning, Jinzhuo, Fan Cheng · 2024 · Figshare
  6. Additional file 1 of Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions
    Guo, Ju, Zhao Wei, Jia, Tianwei, Wang, Liyang, Nuosu Nama, Liang, Jiaqian, Liao, Xinghua, Liu, Xiaming, Gao, Yanfei, Liu, Xiaoqiang et al. · 2023 · Figshare
  7. Additional file 1 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
    Wang, Zefeng, Zheng Chao, Wang, Qi, Fan Zou, Tianbao Song, Lizhe Xu, Ning, Jinzhuo, Cheng, Fan · 2024 · Figshare
  8. Additional file 6 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
    Wang, Zefeng, Chao, Zheng, Wang, Qi, Fan Zou, Tianbao Song, Lizhe Xu, Ning, Jinzhuo, Cheng, Fan · 2024 · Figshare
  9. Additional file 2 of EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
    Wang, Zefeng, Chao, Zheng, Wang, Qi, Fan Zou, Tianbao Song, Lizhe Xu, Ning, Jinzhuo, Cheng, Fan · 2024 · Figshare
  10. Integration of genomic classification and clinical characteristics predicts survival in metastatic prostate cancer
    Martin William Schoen, Jiannong Li, Sihang Zeng, Heena Desai, Ryan M. Hausler, Candace L. Haroldsen, Lukas Owens, Luca Valle, Ruth Etzioni, Timothy Richard Rebbeck et al. · 2026 · medRxiv
  11. Prostate Cancer
    Ivan de Kouchkovsky, Eric Small, Rahul R. Aggarwal · 2026 · Springer eBooks
  12. ADT and activation of HGF and WNT axes in double-null prostate cancer
    Dexter Hoi Long Leung, Yao Mawulikplimi Adzavon, Gaeul Chu, Tae Ju Park, Kristoffer Nikias, Cheong-Wun Kim, Chenmiao Liu, Zijie Sun · 2026 · Nature Reviews Urology
  13. Genomic landscape and clinical impact of BRCA1/2 pathogenic variants in metastatic castration-resistant prostate cancer
    Kazuki Iida, Fumihiko Urabe, Yuya Matsui, Kojiro Tashiro, Kentaro Yoshihara, Yusei Urabe, Takaaki Ishikawa, Juntaro Matsuzaki, Takahiro Kimura, Yoshimasa Saito · 2026 · npj Precision Oncology
  14. A network pharmacology–guided multi-omics and spatial single-cell framework nominates WT1 as a spironolactone-linked immune biomarker in prostate cancer
    Zhen Zhu, Xingjun He · 2026 · Frontiers in Pharmacology
  15. Oncogenes and tumor suppressor genes are enriched in stop-loss mutations generating protein extensions
    Lilian Marie Boll, Joan Antoni Martorell, Nafiseh Khelghati, Marta E. Camarena, Clara Vianello, Juan Carlos García-Soriano, Eva Santamaría, Idoia Artoleta, Silvia Sáez-Valle, J Perera-Bel et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Implication de PXR, Pregnane X Receptor, dans la résistance aux inhibiteurs de kinases en cancérologie : application au cancer de la prostate et mélanome
    Alice Matheux · 2020 · theses.fr (ABES)
  17. The molecular pathology of prostate cancer: an update for practising pathologists
    Fernanda Caramella Pereira, Angelo Michael De Marzo · 2026 · Histopathology
  18. Oncogenic MAGEA4 directs neuroendocrine differentiation and survival in prostate cancer cells through the SIRT1/Acetyl-p53/BCL-2 axis
    Maresha Ramakrishna, Teja Nallavolu, Ramesh Ummanni · 2026 · Molecular Biology Reports
  19. CDK12 and CDK13 suppress distinct intronic polyadenylation sites
    Molly J. Hulver, Andrew Polevoda, Kai-Lieh Huang, Eric J. Wagner, Paul L. Boutz · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Single-Cell Analysis Reveals Pre-Existing Basal-Associated Epithelial States in Metastatic Hormone-Naïve Prostate Cancer
    Ryuta Watanabe, Mami Chosei, Tomohisa Sakaue, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika · 2026 · International Journal of Molecular Sciences
  21. 3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer
    Songyan Qi, Scott M. Dehm · 2026 · Endocrinology
  22. Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer
    Ryan James Rebernick, Liat Hammer, Mahnoor Naseer Gondal, Abhijit Parolia, Yi‐Mi Wu, Noshad Hosseini, Matthew J. Schipper, Anbarasu Kumaraswamy, Matthew McFarlane, Xuhong Cao et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate
    Martin William Schoen, Jiannong Li, Sihang Zeng, Heena Desai, Ryan M. Hausler, Candace L. Haroldsen, Lukas Owens, Luca Valle, Ruth Etzioni, Timothy Richard Rebbeck et al. · 2026 · JCO Precision Oncology
  24. Pipettes and Pipelines: The Weapons of Omics Sciences for a New Age of Clinical Studies
    Ícaro Santos Lopes, Eduardo Rocha Fukutani, Tiago Feitosa Mota, Bruno B. Andrade, Mariana Araújo‐Pereira, Artur T. L. Queiroz · 2026 · Current Issues in Molecular Biology
  25. CXCR2-mediated metabolic interaction between prostate cancer cells and the immunosuppressive tumor microenvironment
    Yi Sun, Jun Jing, Shangqing Ren, Xu Luo, Wei Wen, Xin Jin, Guohua Zeng, Xuewen Jiang, Mo Zhang, Ju Guo · 2026 · Journal for ImmunoTherapy of Cancer
  26. Molecular Oncologic Pathology of Solid and Soft Tissue Tumors
    Yi Ding, Jeffrey W. Kleinberger, Jialing Huang, Hongjie Li, Andrew Campbell · 2026 · Springer eBooks
  27. Subclonal Complete Loss of CDKN1B as a Common Genomic Alteration in Prostate Cancer: Associations With Race and Prostate Cancer Outcomes
    Karen Sandell Sfanos, Rebecca Morton, Julia Flores, Rebecca Y. Sosa, Sarah E. Ernst, Luke A. Mummert, Jessica Hicks, Tamara Levin Lotan, Jiayun Lu, Yuezhou Jing et al. · 2026 · Modern Pathology
  28. The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development
    Timothy J. Mann, Therese M. Becker, Tara Laurine Roberts, Paul DE SOUZA, John George Lock · 2026 · Frontiers in Cell and Developmental Biology
  29. Targeting CDKs in the RNAPII transcription cycle
    Robert P. Fisher, Matthias Geyer · 2026 · Nature Reviews Drug Discovery
  30. Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells
    Konsta Kukkonen, Ebrahim Afyounian, Hanna E. Rauhala, Matti Nykter, Alfonso Urbanucci, Leena Latonen, Tapio Visakorpi · 2026 · Nucleic Acids Research
  31. A novel multiplex digital PCR assay for simultaneous quantification of androgen receptor amplification, mutations, and splice variants in cell-free nucleic acids from metastatic castration-resistant prostate cancer
    Yijun Tian, Jodie Wong, Filip Ionescu, Jingsong Zhang, Alex Soupir, Manish Kohli, Liang Wang · 2026 · The Journal of Liquid Biopsy
  32. Real‐World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON‐3 Study
    Lorena Incorvaia, Veronica Mollica, Ondřej Fiala, Kazutoshi Fujita, Yüksel Ürün, Bohuslav Melichar, Javier Molina‐Cerrillo, Teresa Alonso‐Gordoa, Umberto Basso, Maria Teresa Bourlon et al. · 2026 · The Prostate
  33. The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer
    Diogo Vieira da Silva Pellegrina, Daria Kiriy, Kevin C.L. Cheng, Francesco Favero, Enrichetta Miletti, Zoe P. Klein, Bárbara Hernando, André Vidas Olsen, Atef Sahli, Yunfan Fu et al. · 2026 · Nature Communications
  34. BindingDB Entry 50013848: Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
    BindingDB · 2022 · UC San Diego
  35. BindingDB Entry 50018644: Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist.
    BindingDB · 2024 · UC San Diego
  36. BindingDB Entry 50014488: Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate Cancer.
    BindingDB · 2022 · UC San Diego
  37. BindingDB Entry 50015910: Current progress and novel strategies that target CDK12 for drug discovery.
    BindingDB · 2023 · UC San Diego
  38. Clinical Value of PTEN Loss in Metastatic Hormone-Sensitive Prostate Cancer: From Biomarker to Precision Treatment
    文鑫 拓 · 2026 · Advances in Clinical Medicine